Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting

Dolutegravir’s therapeutic effectiveness in the management of neuroAIDS is mainly limited by its failure to cross the blood–brain barrier. However, lipid-based nanovesicles such as nanoemulsions have demonstrated their potential for the brain targeting of various drugs by intranasal delivery. Thus,...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anroop B. Nair, Sunita Chaudhary, Shery Jacob, Dhwani Patel, Pottathil Shinu, Hiral Shah, Ankit Chaudhary, Bandar Aldhubiab, Rashed M. Almuqbil, Ahmed S. Alnaim, Fatemah Alqattan, Jigar Shah
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-02-01
Schriftenreihe:	Gels
Schlagworte:	NeuroAIDS Dolutegravir nanoemulsion nasal in situ gel mucoadhesive brain targeting
Online-Zugang:	https://www.mdpi.com/2310-2861/9/2/130
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!